Serum Institute of India (SII) | Page 3 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
January 07, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JANUARY 07, 2026

Serum Institute of India (SII)

Serum Institute of India (SII)

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas

Serum CEO ‘flees India’ over threats

I’m staying here (London) an extended time because I don't want to go back to that situation, he says

Beximco profits Tk77 per vaccine brought from India

Beximco profits Tk77 per vaccine brought from India

Photo: NDTV

Covishield production in full swing, says SII CEO Adar Poonawalla

Serum CEO Adar Poonawalla/Courtesy

Serum Institute's Adar Poonawalla to get Y category security across India

A vial of AstraZeneca coronavirus disease (Covid-19) vaccine doses at a facility in Milton, Ontario, Canada, March 3, 2021. REUTERS/Carlos Osorio

Covishield price for Indian states reduced from Rs400 to Rs300 per dose

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

Indian govt tells Serum Institute, Bharat biotech to lower their Covid vaccine prices

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas

‘Covishield most affordable Covid-19 jab’: SII calls out ‘inaccurate comparison’

Serum CEO Adar Poonawalla/Courtesy

Vaccine exports may resume in June-July, Serum CEO hopes

The White House is pictured shortly after sunrise in Washington/Reuters

WH uncertain over lifting curbs on vaccine raw materials export to India

Employees operate a filling machine inside a lab at the Serum Institute of India, in Pune, India, November 30, 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/Files

India to fund capacity boost at Serum Institute as vaccines run short

FILE PHOTO: A woman speaks inside a waiting zone area at a health clinic where COVID-19 vaccination is being given to healthcare workers in Kolkata, India, February 1, 2021. REUTERS/Rupak De Chowdhuri/File Photo

India reports Covid-19 vaccine shortage as second wave surges record highs

Serum CEO Adar Poonawalla/Courtesy

Serum Institute appeals to Biden to lift embargo on raw material exports

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

COVAX says India's Serum Institute bound to supply virus vaccines

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net